Combined Carfilzomib and Hydroxychloroquine in Patients With Relapsed/Refractory Multiple Myeloma

Condition:   Multiple Myeloma Interventions:   Drug: Hydroxychloroquine;   Drug: Carfilzomib Injection;   Drug: Dexamethasone Sponsors:   Norwegian University of Science and Technology;   St. Olavs Hospital;   Oslo University Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials